Zenshine Pharma Files for Hong Kong IPO with $357M Valuation
CompanyDeals

Zenshine Pharma Files for Hong Kong IPO with $357M Valuation

CompanyDeals

Moderna Partners with Recordati on mRNA-3927 for Rare Propionic Acidemia

CompanyDeals

Illumina Completes $350M SomaLogic Acquisition to Expand Proteomics Portfolio

CompanyMedical Device

Microport EP Medtech’s EasyEcho ICE Catheter Wins NMPA Market Clearance

Policy / Regulatory

NHSA Targets NRDL Fund Supervision in 2026 Crackdown

Regeneron Q4 Revenue Grows 3% to $3.9B on EYLEA HD and Dupixent Strength
Company

Regeneron Q4 Revenue Grows 3% to $3.9B on EYLEA HD and Dupixent Strength

Vcare Pharma Partners with Sun-Novo on VC005 JAK1 Inhibitor for Atopic Dermatitis
CompanyDeals

Vcare Pharma Partners with Sun-Novo on VC005 JAK1 Inhibitor for Atopic Dermatitis

Sciwind's Ecnoglutide Wins NMPA Nod as First cAMP‑Biased GLP‑1 Agonist
CompanyDrug

Sciwind’s Ecnoglutide Wins NMPA Nod as First cAMP‑Biased GLP‑1 Agonist

FDA Opens PreCheck Applications to Strengthen Domestic Drug Manufacturing
Policy / Regulatory

FDA Opens PreCheck Applications to Strengthen Domestic Drug Manufacturing

Ab&b Bio-Tech's Trivalent Influenza Vaccine Wins NMPA Nod for All Ages
CompanyDrug

Ab&b Bio-Tech’s Trivalent Influenza Vaccine Wins NMPA Nod for All Ages

Sanofi Rezurock Wins EU Backing for Graft‑Versus‑Host Disease
CompanyDrug

Sanofi Rezurock Wins EU Backing for Graft‑Versus‑Host Disease

CMS-D017 Gets NMPA Nod for PNH Clinical Trial
CompanyDrug

CMS-D017 Gets NMPA Nod for PNH Clinical Trial